COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,788 Articles (22,946 medRxiv, 8,842 bioRxiv)

Most recent first Previous |  Page 102: Articles 1011-1020  | Next

Real-world effectiveness and non-inferiority evaluation and comparison of mRNA- and protein-based COVID-19 vaccines: a randomized study protocol (BEEHIVE)
Yoon, S. K., Ellsworth, G. L., Battan-Wraith, S., Phillips, A. L., Fink, R. V., Griffin, J., Rowley, E. A. K., McKell, J., Smith, A. S., Campbell, R., Williams, J., Ball, S. W., Zhao, H., Warren, B., Rousculp, M. D., Thiese, M. S.
10.1101/2025.07.21.25331726 — Posted: 2025-07-23
Analysis of MPXV RNA-seq Data Reveals Lack of Evidence of APOBEC3-mediated RNA Editing
Lyskova, A. O., Abasov, R. K., Pavlova, A., Matveev, E., Madorskaya, A. V., Kazanov, F. M., Ponomarev, G. V., Ivankov, D. N., Adebali, O., Gelfand, M. S., Kazanov, M. D.
10.1101/2025.07.21.665962 — Posted: 2025-07-22
SARS-CoV-2 sero-surveillance after the first and second waves of the epidemic in Panama
Lezcano-Coba, C., Galue, J., Whittaker, C., Mills, C., de Antonio, R., Saenz-llorens, X., Rivera, L. F., Rodriguez, X., Franco, D., Rebollon, A., Espinosa, E., Castillo-Castillo, C., Martinez, A., Martinez, M., Leon, X., Rios, A., Arauz, J., Gonzalez, P., Dominguez, C., Lopez-Verges, S., Gonzalez, B., Jimeno, J., Valderrama, A., Murgas, I., Hanley, K. A., Vasilakis, N., Dorigatti, I., Bueneman, M., Faria, N. R., Kraemer, M., Armien, B., Donnelly, C. A., Carrera, J. P.
10.1101/2025.07.20.25331847 — Posted: 2025-07-21
Iodine increases pulmonary type I interferon responses and decreases COVID-19 disease severity: results from an open-label randomized clinical trial
Traksel, R. A. M., Broen, J. C. A., van Henten, A. M. J., Konigs, M. H. H., Raj, A., Van Eyndhoven, L. C., Verheesen, R. H.
10.1101/2025.07.18.25331773 — Posted: 2025-07-21
Environmental Profiles and COVID-19 Mortality Risk: A Latent Class Analysis of Intensive Care Patients in the Early Pandemic
Wang, W., Li, D., Zhang, L. L., Eskell, M., Clark, B., Damodaran, A., Mullhi, R., Veenith, T., An, Y., Smith, F. G., Li, H.
10.1101/2025.07.20.25331858 — Posted: 2025-07-21
Charged Scanning Mutagenesis as a High Throughput Approach for Epitope Mapping
Kanjo, K., Bhasin, M., Dey, C., Bakshi, N., Asok, A., Singh, R., Kumar, S., Ringe, R. P., Varadarajan, R.
10.1101/2025.07.20.665262 — Posted: 2025-07-21
Dynamic Culture Improves the Predictive Power of Bronchial and Alveolar Airway Models of SARS-CoV-2 Infection
Caygill, C. H., Lopeman, R., Lewis, K. A., Richardson, E., Casas-Sanchez, A., Heavey, N., Winrow, A., Williams, C., Wooding, D., Edwards, T., Lucas, E. R., Kostrzewski, T., Owen, A. R., Pennington, S. H., Biagini, G. A.
10.1101/2025.07.21.665885 — Posted: 2025-07-21
Antibody evasion and receptor binding of SARS-CoV-2 LP.8.1.1, NB.1.8.1, XFG, and related subvariants
Mellis, I. A., Wu, M., Hong, H., Tzang, C.-C., Bowen, A., Wang, Q., Gherasim, C., Pierce, V. M., Shah, J. G., Purpura, L. J., Yin, M. T., Gordon, A., Guo, Y., Ho, D. D.
10.1101/2025.07.18.662329 — Posted: 2025-07-21
Nationwide survey of municipal policies and COVID-19 vaccination uptake among older adults in Japan during 2024-2025
Machida, M., Nomachi, A., Tanabe, K., Ito, S., Nakaya, T., Matono, T.
10.1101/2025.07.17.25330544 — Posted: 2025-07-18
Covariance-Based MD Simulation Analysis Pinpoints Nanobody Attraction and Repulsion Sites on SARS-CoV-2 Omicron Spike Protein
Golcuk, M., Abu-Juam, F. E., Basturk, D., Gursel, A. D., Buran, C. X., Metin-Akkaya, R., Yildiz, A., Gur, M.
10.1101/2025.07.18.665531 — Posted: 2025-07-18

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).